Eckel's most recent trade in Five Below Inc was a trade of 155 Common Stock done at an average price of $136.5 . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 136.53 per share. | 04 Aug 2025 | 155 | 4,511 (0%) | 0% | 136.5 | 21,162 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.75 per share. | 27 Jun 2025 | 8,619 | 404,258 (2%) | 0% | 20.7 | 178,844 | Common Stock |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 1,389 | 4,356 (0%) | 0% | 0 | Common Stock | |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,166 | 754,627 | - | - | LTIP Units | |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 82.79 per share. | 05 May 2025 | 270 | 2,967 (0%) | 0% | 82.8 | 22,353 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 64,824 | 424,004 (2%) | 0% | 0 | Common Stock | |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.00 per share. | 04 Apr 2025 | 11,127 | 412,877 (2%) | 0% | 18 | 200,286 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 59,208 | 749,461 | - | - | LTIP Units | |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 92.33 per share. | 03 Feb 2025 | 242 | 2,697 (0%) | 0% | 92.3 | 22,344 | Common Stock |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 95.00 per share. | 04 Nov 2024 | 234 | 2,455 (0%) | 0% | 95 | 22,230 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 34.92 per share. | 13 Sep 2024 | 109,670 | 473,049 (0%) | 0% | 34.9 | 3,829,676 | Common stock, par value $0.01 per share |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 34.75 per share. | 13 Sep 2024 | 36,330 | 436,719 (0%) | 0% | 34.8 | 1,262,468 | Common stock, par value $0.01 per share |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Other type of transaction at price $ 0.00 per share. | 13 Sep 2024 | 18,450 | 18,450 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Other type of transaction at price $ 0.00 per share. | 13 Sep 2024 | 18,450 | 455,169 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.86 per share. | 28 Jun 2024 | 15,142 | 359,180 (2%) | 0% | 25.9 | 391,572 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 5.64 per share. | 17 Jun 2024 | 2,660 | 25,450 (0%) | 0% | 5.6 | 14,998 | Common Stock |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 1,454 | 2,221 (0%) | 0% | 0 | Common Stock | |
| Inhibrx Biosciences Inc. | Brendan P. Eckelman | Chief Scientific Officer | 29 May 2024 | 433,888 | 433,888 | - | - | Common Stock | ||
| Inhibrx Biosciences Inc. | Brendan P. Eckelman | Chief Scientific Officer | 29 May 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | ||
| Inhibrx Biosciences Inc. | Brendan P. Eckelman | Chief Scientific Officer | 29 May 2024 | 40,000 | 40,000 | - | - | Common Stock | ||
| Inhibrx Biosciences Inc. | Brendan P. Eckelman | Chief Scientific Officer | 29 May 2024 | 40,000 | 40,000 | - | - | Common Stock | ||
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 2,510 | 6,667 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 2,500 | 26,667 | - | - | Stock Option (right to buy) | |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 64,580 | 377,793 (2%) | 0% | 0 | Common Stock | |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.91 per share. | 04 Apr 2024 | 3,471 | 374,322 (2%) | 0% | 26.9 | 93,405 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.86 per share. | 24 Mar 2024 | 3,143 | 313,213 (2%) | 0% | 26.9 | 84,421 | Common Stock |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 15 Mar 2024 | 13,735 | 342,232 (1%) | 0% | 1.7 | 22,881 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.22 per share. | 15 Mar 2024 | 228 | 22,551 (0%) | 0% | 6.2 | 1,418 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 1,898 | 9,177 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 19,898 | 11,075 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 6,877 | 30,973 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 6,681 | 33,319 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 4,152 | 29,167 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 2,150 | 37,850 | - | - | Stock Option (right to buy) | |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,000 | 778,117 | - | - | LTIP Units | |
| Aware Inc. | Eckel E. Robert | Director, CEO & President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Feb 2024 | 1,250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aware Inc. | Eckel Robert E. | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 619,000 | 619,000 | - | - | Stock Option (Right to Buy) | |
| Aware Inc. | Robert Eckel E. | Director, CEO & President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aware Inc. | Eckel Robert E. | Director, CEO & President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Hannon Armstrong Sustainab... | Eckel W. Jeffrey | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2024 | 34,836 | 0 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Hannon Armstrong Sustainab... | Eckel Jeffrey W. | Director, Executive Chair | Other type of transaction at price $ 0.00 per share. | 20 Feb 2024 | 32,825 | 34,836 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Hannon Armstrong Sustainab... | Eckel Jeffrey W. | Director, Executive Chair | Other type of transaction at price $ 0.00 per share. | 20 Feb 2024 | 32,825 | 582,719 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.79 per share. | 15 Dec 2023 | 206 | 22,323 (0%) | 0% | 6.8 | 1,399 | Common Stock |
| Aware Inc. | E. Eckel Robert | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 13 Dec 2023 | 17,000 | 328,407 (1%) | 0% | 1.6 | 27,564 | Common Stock |
| Aware Inc. | Eckel E. Robert | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 13 Dec 2023 | 3,000 | 311,497 (1%) | 0% | 1.6 | 4,815 | Common Stock |
| FNCB Bancorp Inc | Keith Eckel W. | Director | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 30 Nov 2023 | 41 | 22,116 (0%) | 0% | 6.1 | 250 | Common Stock |
| Five Below Inc | Mimi Eckel Vaughn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 767 | 767 (0%) | 0% | 0 | Common Stock | |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 5.95 per share. | 31 Aug 2023 | 42 | 21,778 (0%) | 0% | 6.0 | 250 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 19.76 per share. | 21 Aug 2023 | 2,525 | 19,162 (0%) | 0% | 19.8 | 49,894 | Common stock, par value $0.01 per share |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 19.75 per share. | 21 Aug 2023 | 351 | 2,887 (0%) | 0% | 19.7 | 6,932 | Common stock, par value $0.01 per share |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.25 per share. | 31 Jul 2023 | 40 | 21,736 (0%) | 0% | 6.3 | 250 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.11 per share. | 30 Jun 2023 | 2,454 | 21,695 (0%) | 0% | 6.1 | 15,001 | COMMON STOCK |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 30 Jun 2023 | 41 | 19,241 (0%) | 0% | 6.1 | 250 | COMMON STOCK |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 28 Jun 2023 | 18,484 | 316,333 (2%) | 0% | 24.3 | 448,422 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.59 per share. | 15 Jun 2023 | 170 | 19,199 (0%) | 0% | 6.6 | 1,121 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 5.68 per share. | 31 May 2023 | 44 | 19,028 (0%) | 0% | 5.7 | 250 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.95 per share. | 30 May 2023 | 4,300 | 334,817 (2%) | 0% | 19.0 | 81,485 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.85 per share. | 30 May 2023 | 2,100 | 329,617 (2%) | 0% | 18.9 | 39,585 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.65 per share. | 30 May 2023 | 1,700 | 326,617 (2%) | 0% | 18.7 | 31,705 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.76 per share. | 30 May 2023 | 700 | 327,417 (2%) | 0% | 18.8 | 13,132 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.90 per share. | 30 May 2023 | 344 | 329,961 (2%) | 0% | 18.9 | 6,502 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.91 per share. | 30 May 2023 | 206 | 330,167 (2%) | 0% | 18.9 | 3,895 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.93 per share. | 30 May 2023 | 200 | 330,517 (2%) | 0% | 18.9 | 3,786 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.92 per share. | 30 May 2023 | 150 | 330,317 (2%) | 0% | 18.9 | 2,838 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.82 per share. | 30 May 2023 | 100 | 327,517 (2%) | 0% | 18.8 | 1,882 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.64 per share. | 30 May 2023 | 100 | 324,917 (2%) | 0% | 18.6 | 1,864 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.76 per share. | 30 May 2023 | 100 | 326,717 (2%) | 0% | 18.8 | 1,876 | Common Stock |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.58 per share. | 26 May 2023 | 10,000 | 278,497 (1%) | 0% | 1.6 | 15,843 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 01 May 2023 | 41 | 18,984 (0%) | 0% | 6.1 | 250 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 42,762 | 324,817 (2%) | 0% | 0 | Common Stock | |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 6.41 per share. | 31 Mar 2023 | 39 | 18,942 (0%) | 0% | 6.4 | 250 | Common Stock |
| Genesco Inc. | Mimi Eckel Vaughn | Director, Board Chair, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 24 Mar 2023 | 6,286 | 282,055 (1%) | 0% | 35.2 | 221,519 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 23.92 per share. | 16 Mar 2023 | 2,087 | 549,894 (0%) | 0% | 23.9 | 49,921 | Common stock, par value $0.01 per share |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 7.31 per share. | 15 Mar 2023 | 150 | 18,903 (0%) | 0% | 7.3 | 1,096 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 173,299 | 758,117 | - | - | LTIP Units | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.20 per share. | 01 Mar 2023 | 39,600 | 2,035,953 | - | 24.2 | 958,348 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.71 per share. | 01 Mar 2023 | 400 | 2,035,553 | - | 24.7 | 9,883 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 28 Feb 2023 | 31 | 18,753 (0%) | 0% | 8.1 | 250 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 01 Feb 2023 | 14,608 | 2,087,496 | - | 25.1 | 366,366 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 01 Feb 2023 | 13,449 | 2,102,104 | - | 24.3 | 326,710 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.40 per share. | 01 Feb 2023 | 10,120 | 2,076,683 | - | 25.4 | 257,094 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.89 per share. | 01 Feb 2023 | 1,130 | 2,075,553 | - | 25.9 | 29,261 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.66 per share. | 01 Feb 2023 | 693 | 2,086,803 | - | 25.7 | 17,780 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 31 Jan 2023 | 31 | 18,721 (0%) | 0% | 8.1 | 250 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 23.41 per share. | 03 Jan 2023 | 22,213 | 2,133,340 | - | 23.4 | 520,051 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.36 per share. | 03 Jan 2023 | 8,598 | 2,124,742 | - | 24.4 | 209,426 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 23.11 per share. | 03 Jan 2023 | 4,102 | 2,118,556 | - | 23.1 | 94,786 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 23.99 per share. | 03 Jan 2023 | 3,003 | 2,115,553 | - | 24.0 | 72,043 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.09 per share. | 03 Jan 2023 | 2,084 | 2,122,658 | - | 25.1 | 52,293 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 03 Jan 2023 | 31 | 18,689 (0%) | 0% | 8.1 | 250 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 8.34 per share. | 15 Dec 2022 | 129 | 18,658 (0%) | 0% | 8.3 | 1,076 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.83 per share. | 06 Dec 2022 | 20,927 | 2,174,626 | - | 26.8 | 561,572 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.57 per share. | 06 Dec 2022 | 17,681 | 2,156,945 | - | 27.6 | 487,493 | Common Stock |
| Inhibrx Inc | Brendan P. Eckelman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.46 per share. | 06 Dec 2022 | 1,392 | 2,155,553 | - | 28.5 | 39,617 | Common Stock |
| FNCB Bancorp Inc | Keith W. Eckel | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 30 Nov 2022 | 31 | 18,529 (0%) | 0% | 8.1 | 250 | Common Stock |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 10 Nov 2022 | 14,000 | 263,497 (1%) | 0% | 1.7 | 23,800 | Common Stock |
| Hannon Armstrong Sustainab... | Jeffrey W. Eckel | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 29.26 per share. | 09 Nov 2022 | 10,000 | 547,807 (0%) | 0% | 29.3 | 292,600 | Common stock, par value $0.01 per share |
| Aware Inc. | Robert E. Eckel | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 02 Nov 2022 | 25,000 | 249,497 (1%) | 0% | 1.6 | 38,750 | Common Stock |